Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Fixed combinations in arterial hypertension treatment: Novel opportunities

Подзолков В. И., Тарзиманова А. И.
Российский кардиологический журнал
Вып. 5, С. 68-73
Опубликовано: 2018
Тип ресурса: Статья

DOI:10.15829/1560-4071-2018-5-68-73

Аннотация:
Arterial hypertension (AH) remains one of the most prevalent cardiovascular disorder in the world, as one of the main risk factors of myocardial infarction and stroke development. Monotherapy of AH is effective in no more than one half of patients even with moderate increase of blood pressure. Combinational antihypertension treatment does influence pathogenetic mechanisms of AH being an optimal solution. It is worthful to apply a fixed combination of telmisartan and hydrochlorothiazide. Such combination provides additional antihypertensive effect with more significant decrease of blood pressure than for the components separately. Also it is protective for organs and tissues that makes it to prescribe such combination to a broad range of patients. © Russian Journal of Cardiology.
Ключевые слова:
Combination treatment; Hydrochlorothiazide; Systemic hypertension; Telmisartan
antihypertensive agent; hydrochlorothiazide plus telmisartan; antihypertensive activity; Article; cardiovascular disease; cerebrovascular accident; elevated blood pressure; heart infarction; human; hypertension; monotherapy; risk factor
Язык текста: Русский
ISSN: 2618-7620
Подзолков В. И. Валерий Иванович 1948-
Тарзиманова А. И. Аида Ильгизовна 1978-
Podzolkov V. I. Valerij Ivanovich 1948-
Tarzimanova A. I. Aida Il`gizovna 1978-
Fixed combinations in arterial hypertension treatment: Novel opportunities
Текст визуальный непосредственный
Российский кардиологический журнал
ООО "Силицея-Полиграф"
Вып. 5 С. 68-73
2018
Статья
Combination treatment Hydrochlorothiazide Systemic hypertension Telmisartan
antihypertensive agent hydrochlorothiazide plus telmisartan antihypertensive activity Article cardiovascular disease cerebrovascular accident elevated blood pressure heart infarction human hypertension monotherapy risk factor
Arterial hypertension (AH) remains one of the most prevalent cardiovascular disorder in the world, as one of the main risk factors of myocardial infarction and stroke development. Monotherapy of AH is effective in no more than one half of patients even with moderate increase of blood pressure. Combinational antihypertension treatment does influence pathogenetic mechanisms of AH being an optimal solution. It is worthful to apply a fixed combination of telmisartan and hydrochlorothiazide. Such combination provides additional antihypertensive effect with more significant decrease of blood pressure than for the components separately. Also it is protective for organs and tissues that makes it to prescribe such combination to a broad range of patients. © Russian Journal of Cardiology.